Lorenz Muller's most recent trade in Milestone Pharmaceuticals Inc was a trade of 66,666 Common Shares done . Disclosure was reported to the exchange on July 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 66,666 | 175,052 (0%) | 0% | - | Common Shares | |
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 66,666 | 66,666 | - | - | Series B Common Warrants (right to buy) | |
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 66,666 | 66,666 | - | - | Series A Common Warrants (right to buy) | |
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 120,600 | 120,600 | - | - | Employee Stock Option (right to buy) | |
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 80,400 | 80,400 | - | - | Restricted Stock Unit | |
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 160,000 | 160,000 | - | - | Employee Stock Option Grant (right to buy) | |
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2020 | 5,700 | 49,754 | - | - | Employee Stock Option (right to buy) | |
Milestone Pharmaceuticals Inc | Lorenz Muller | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.54 per share. | 26 Aug 2020 | 5,700 | 108,386 (0%) | 0% | 1.5 | 8,778 | Common Stock |